Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance
Top Cited Papers
- 1 January 2004
- journal article
- research article
- Published by Elsevier
- Vol. 164 (1) , 217-227
- https://doi.org/10.1016/s0002-9440(10)63112-4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U01 CA84999)
This publication has 32 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Squalene epoxidase as hypocholesterolemic drug target revisitedProgress in Lipid Research, 2003
- The program of androgen-responsive genes in neoplastic prostate epitheliumProceedings of the National Academy of Sciences, 2002
- Transcriptional programs activated by exposure of human prostate cancer cells to androgenGenome Biology, 2002
- Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingOncogene, 2001
- Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part SarcomaThe American Journal of Pathology, 2001
- Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate CancerNew England Journal of Medicine, 2001
- ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCERJournal of Urology, 2000
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- Clinical and Pathobiological Effects of Neoadjuvant Total Androgen Ablation Therapy on Clinically Localized Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1994